Stock-Out of Mucosolate, Lemalc Due to Non-Conformance Results of Dissolution Testing, Stable Supply to Resume Next Spring: Teva Pharma Japan

Teva Pharma Japan has revealed that a stock-out for the extended-release expectorant Mucosolate L Cap.45 (ambroxol) and the anti-rheumatoid treatment Lemalc Tab. 100 (bucillamine) was due to the non-conformance results of dissolution testing conducted at the company prior to shipment...read more